Literature DB >> 96131

Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function.

E W Gelfand, H M Dosch, W D Biggar, I H Fox.   

Abstract

Immune function in two brothers with a deficiency of purine nucleoside phosphorylase was evaluated in vivo and in vitro. Both patients had a history of recurrent infections and profound lymphopenia. Studies of cell-mediated immunity revealed an absence of delayed cutaneous reactivity to a number of antigens, including dinitrochlorobenzene, and significantly reduced lymphocyte proliferative responses to nonspecific mitogens, specific antigen, and allogeneic cells. E-rosetting cells were present but reduced in number (20.0% and 31.5%). Serum immunoglobulin levels, percentages of circulating immunoglobulin-and C3-receptor-bearing B cells, as well as the ability to produce antibody in response to specific antigen in vivo were normal. Moreover, studies of the in vitro induction of specific IgM antibody delineated the presence of T-helper and T-regulator cells. The normal induction of bone marrow precursor T-cell maturation by human thymic epithelium-conditioned medium or thymosin suggested that the initial stages of T-cell generation were intact in these patients. Attempts to reconstitute the in vitro proliferative response with a variety of reagents, including purine nucleoside phosphorylase itself, were unsuccessful. Selective impairment of certain aspects of T-cell function in these patients and a less severe clinical picture than previously described may be explained by the presence of a partial deficiency of nucleoside phosphorylase activity and incomplete block of purine catabolism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96131      PMCID: PMC372624          DOI: 10.1172/JCI109006

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Adenosine deaminase from human erythrocytes: purification and effects of adenosine analogs.

Authors:  R P Agarwal; S M Sagar; R E Parks
Journal:  Biochem Pharmacol       Date:  1975-03-15       Impact factor: 5.858

2.  Role of the C3 receptor in antibody-dependent cytotoxicity.

Authors:  E W Gelfand
Journal:  Transplantation       Date:  1976-01       Impact factor: 4.939

3.  Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease.

Authors:  K W Pyke; H Dosch; M M Ipp; E W Gelfand
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

4.  Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.

Authors:  E W Gelfand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

5.  Detection of T-precursor cells in human bone marrow and foetal liver.

Authors:  K W Pyke; E W Gelfand
Journal:  Differentiation       Date:  1976-06-04       Impact factor: 3.880

6.  Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  S H Polmar; R C Stern; A L Schwartz; E M Wetzler; P A Chase; R Hirschhorn
Journal:  N Engl J Med       Date:  1976-12-09       Impact factor: 91.245

7.  Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.

Authors:  J W Stoop; B J Zegers; G F Hendrickx; L H van Heukelom; G E Staal; P K de Bree; S K Wadman; R E Ballieux
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

8.  Thymosin activity in patients with cellular immunodeficiency.

Authors:  D W Wara; A L Goldstein; N E Doyle; A J Ammann
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

9.  Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.

Authors:  B Ullman; A Cohen; D W Martin
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

10.  Purine dysfunction in cells from patients with adenosine deaminase deficiency.

Authors:  P J Benke; D Dittmar
Journal:  Pediatr Res       Date:  1976-07       Impact factor: 3.756

View more
  9 in total

1.  Adenosine receptor lymphocytes in humoral immunodeficiency.

Authors:  A Saxon; C J Thiele; C Moroz; R H Stevens
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

2.  Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes.

Authors:  G E Staal; J W Stoop; B J Zegers; L H Siegenbeek van Heukelom; M J van der Vlist; S K Wadman; D W Martin
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

Review 3.  Nucleotide-metabolizing enzymes and lymphocyte differentiation.

Authors:  R W Barton; I Goldschneider
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

4.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

5.  Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function.

Authors:  E W Gelfand; J J Lee; H M Dosch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.

Authors:  I H Fox; J Kaminska; N L Edwards; E Gelfand; K C Rich; W N Arnold
Journal:  Biochem Genet       Date:  1980-04       Impact factor: 1.890

7.  Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.

Authors:  D A Carson; D B Wasson; E Lakow; N Kamatani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

8.  The Broad Clinical Spectrum and Transplant Results of PNP Deficiency.

Authors:  Polina Stepensky; Irina Zaidman; Yael Dinur Schejter; Ehud Even-Or; Bella Shadur; Adeeb NaserEddin
Journal:  J Clin Immunol       Date:  2019-11-09       Impact factor: 8.542

9.  Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral lymphocytes from patients with solid tumours.

Authors:  M Russo; R Giancane; G Apice; B Galanti
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.